Matches in Wikidata for { <http://www.wikidata.org/entity/Q37283073> ?p ?o ?g. }
- Q37283073 description "article científic" @default.
- Q37283073 description "article scientifique" @default.
- Q37283073 description "articolo scientifico" @default.
- Q37283073 description "artigo científico" @default.
- Q37283073 description "artículu científicu espublizáu en 2009" @default.
- Q37283073 description "bilimsel makale" @default.
- Q37283073 description "scientific article published on February 2009" @default.
- Q37283073 description "vedecký článok" @default.
- Q37283073 description "vetenskaplig artikel" @default.
- Q37283073 description "videnskabelig artikel" @default.
- Q37283073 description "vědecký článek" @default.
- Q37283073 description "wetenschappelijk artikel" @default.
- Q37283073 description "wissenschaftlicher Artikel" @default.
- Q37283073 description "наукова стаття, опублікована в лютому 2009" @default.
- Q37283073 description "научни чланак" @default.
- Q37283073 description "مقالة علمية نشرت في فبراير 2009" @default.
- Q37283073 name "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 name "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 name "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 type Item @default.
- Q37283073 label "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 label "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 label "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 prefLabel "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 prefLabel "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 prefLabel "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy." @default.
- Q37283073 P1433 Q37283073-42F7AF0D-5D34-4C75-84AB-9BAE39ACB924 @default.
- Q37283073 P1476 Q37283073-5851CCBA-2353-4AF1-99B9-A7C6F0128FC0 @default.
- Q37283073 P2093 Q37283073-3279B6E5-4713-473F-A2D3-57D63199BF93 @default.
- Q37283073 P2093 Q37283073-3722A93B-AF6C-4DF7-8FD4-C0AFC110D721 @default.
- Q37283073 P2093 Q37283073-5785CB44-DBE2-4FAD-BD38-59A4D0AFE895 @default.
- Q37283073 P2093 Q37283073-760D50D7-F294-4D5D-9BA8-AEDF046735D4 @default.
- Q37283073 P2093 Q37283073-AEB7CC76-155E-432C-AFD7-B891744307F5 @default.
- Q37283073 P2093 Q37283073-AF8FED43-501E-42FA-8053-1632B8DE0FA0 @default.
- Q37283073 P2093 Q37283073-E58791FB-6C5A-4910-B694-69F9FD23EF2F @default.
- Q37283073 P2093 Q37283073-ED08017C-68CE-4263-900B-E6B6E5CD475F @default.
- Q37283073 P2860 Q37283073-0876AE76-349F-4DAC-B6B5-3B0DD2D1B83F @default.
- Q37283073 P2860 Q37283073-16454DEE-46A7-475F-85E9-2A16560D368E @default.
- Q37283073 P2860 Q37283073-205DDCC4-2246-4AC9-A436-751B01117B82 @default.
- Q37283073 P2860 Q37283073-24F40F84-7EBA-4DD9-96AB-1B95CD76C5D9 @default.
- Q37283073 P2860 Q37283073-26CD2806-EB2B-49E2-8BF9-987CBDCE26E5 @default.
- Q37283073 P2860 Q37283073-2E44B5E3-19CE-4B0E-9CC4-1A079E9FD360 @default.
- Q37283073 P2860 Q37283073-4269C98B-F2C6-4895-9F93-17578CD4E65F @default.
- Q37283073 P2860 Q37283073-54F75E0F-9F93-40A9-93E6-3BAFE253E69C @default.
- Q37283073 P2860 Q37283073-5556D042-6315-4ADD-9BE0-9391E79C0954 @default.
- Q37283073 P2860 Q37283073-640D676F-6B12-4805-B15C-91F46E50CE4B @default.
- Q37283073 P2860 Q37283073-65BA1454-42AC-4D89-83D2-844CC3D04AC9 @default.
- Q37283073 P2860 Q37283073-662CAB5A-8117-493A-8CB0-A87E03654A05 @default.
- Q37283073 P2860 Q37283073-69FBB312-AA4B-427F-AC52-5E615A7DDDED @default.
- Q37283073 P2860 Q37283073-7439A60B-90FF-4A3D-BAB8-CA3E300C1388 @default.
- Q37283073 P2860 Q37283073-962382B5-ED83-463C-A39B-6C431BD6D208 @default.
- Q37283073 P2860 Q37283073-A17E201B-D3B3-451F-80B6-6BDA29C1C196 @default.
- Q37283073 P2860 Q37283073-C92AA6B9-6331-4DBD-9A42-4C68194AF8F1 @default.
- Q37283073 P2860 Q37283073-CC8B4C3B-42FA-4F89-9F99-569DEF0D21D9 @default.
- Q37283073 P2860 Q37283073-DBB9BF3D-A40B-4D95-ABC8-A66ABFFE048E @default.
- Q37283073 P2860 Q37283073-DE309FF3-D249-4748-A669-FF0ED56AC524 @default.
- Q37283073 P2860 Q37283073-DF7F58CF-8412-4C48-B41D-F4C2F92CF013 @default.
- Q37283073 P2860 Q37283073-E3E00452-10B2-454D-9785-46C6EDEE4619 @default.
- Q37283073 P2860 Q37283073-E4021190-BA16-4FA7-9142-18D5C2CCE561 @default.
- Q37283073 P304 Q37283073-63B01161-7E4D-4298-B861-6A17FDCAE57B @default.
- Q37283073 P31 Q37283073-29823709-B9E9-42DA-86D2-E67E0DD1428C @default.
- Q37283073 P356 Q37283073-2BD766AD-8D97-4875-B146-87123900C140 @default.
- Q37283073 P407 Q37283073-579EC688-4456-4799-9106-02E9603EE5BE @default.
- Q37283073 P433 Q37283073-7FF997D0-63B1-454F-BABC-3647FAB56C78 @default.
- Q37283073 P478 Q37283073-6043FDBD-54CC-4483-8991-C47CA8AFEEDC @default.
- Q37283073 P50 Q37283073-49A552A6-0A92-4B7A-9AA8-23E1D892935F @default.
- Q37283073 P50 Q37283073-853ECAC7-B4CE-4AA9-AE94-5D51FEA02E75 @default.
- Q37283073 P577 Q37283073-E513BAFF-8E15-4C69-B91F-8AFC4B210828 @default.
- Q37283073 P5875 Q37283073-CE26DE0B-FA89-488D-8C03-94EBFDB0A53A @default.
- Q37283073 P698 Q37283073-875698C7-AF86-49B9-B41E-6975D2B8A5D3 @default.
- Q37283073 P8608 Q37283073-95C2E361-C243-4751-AB8F-61A33C728A70 @default.
- Q37283073 P921 Q37283073-A81E63C1-B893-468F-9DC0-89850FE19E05 @default.
- Q37283073 P932 Q37283073-7AF1FF89-A8D5-41EF-B2A3-0F9B8FC60940 @default.
- Q37283073 P356 1078-0432.CCR-08-1141 @default.
- Q37283073 P698 19228742 @default.
- Q37283073 P1433 Q332253 @default.
- Q37283073 P1476 "Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy" @default.
- Q37283073 P2093 "Elise C Kohn" @default.
- Q37283073 P2093 "Lokesh Jain" @default.
- Q37283073 P2093 "Maria L Turner" @default.
- Q37283073 P2093 "Martin Gutierrez" @default.
- Q37283073 P2093 "Nilofer S Azad" @default.
- Q37283073 P2093 "Seth M Steinberg" @default.
- Q37283073 P2093 "William D Figg" @default.
- Q37283073 P2093 "William L Dahut" @default.
- Q37283073 P2860 Q27860904 @default.
- Q37283073 P2860 Q28282767 @default.
- Q37283073 P2860 Q28299858 @default.
- Q37283073 P2860 Q29616236 @default.
- Q37283073 P2860 Q33380559 @default.
- Q37283073 P2860 Q33767866 @default.
- Q37283073 P2860 Q34710639 @default.
- Q37283073 P2860 Q35608349 @default.
- Q37283073 P2860 Q36512910 @default.
- Q37283073 P2860 Q36615874 @default.
- Q37283073 P2860 Q36692604 @default.
- Q37283073 P2860 Q36807146 @default.
- Q37283073 P2860 Q37054905 @default.
- Q37283073 P2860 Q37062140 @default.
- Q37283073 P2860 Q46666366 @default.